Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Genes|November 16, 2018
Unintentional Genomic Changes Endow <i>Cupriavidus metallidurans</i> with an Augmented Heavy-Metal ResistanceFelipe A Millacura, Paul J Janssen, Pieter Monsieurs, et al.
Biological Research|September 12, 2009
Analysis of the intronic single nucleotide polymorphism rs#466452 of the nephrin gene in patients with diabetic nephropathyRodrigo González, Ares Tirado, Luis A Rojas, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|February 9, 2013
Alteplase use for malfunctioning central venous catheters correlates with catheter-associated bloodstream infectionsCourtney M Rowan, Kathryn E Miller, Andrew L Beardsley, et al.
Microorganisms|November 27, 2025
Characterization of Bacterial Communities in Volcanic Soil from Northern Patagonian Area of ChilePatricia Aguila-Torres, Mauricio González, Marcela Hernández, et al.
Journal of Neuroinflammation|April 20, 2021
4R-cembranoid confers neuroprotection against LPS-induced hippocampal inflammation in miceLuis A Rojas-Colón, Pramod K Dash, Fabiola A Morales-Vías, et al.
Cells|February 26, 2026
Gender-Associated Differences in the Regulation of Potassium Channels in Astrocytes of Type 2 Diabetic MiceLuis A Rojas-Colón, David E Rivera-Aponte, Jadier Colón-Vázquez, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 6, 2021
Oncolytic adenovirus with hyaluronidase activity that evades neutralizing antibodies: VCN-11Ana Mato-Berciano, Sara Morgado, María V Maliandi, et al.
Nature|February 21, 2020
ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunityJohn Alec Moral, Joanne Leung, Luis A Rojas, et al.
Iscience|December 8, 2021
<i>MYC</i> dosage compensation is mediated by miRNA-transcription factor interactions in aneuploid cancerManSai Acón, Carsten Geiß, Jorge Torres-Calvo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2026
Phase I trial of intravenous VCN-01 oncolytic adenovirus and durvalumab in patients with head and neck metastatic squamous cell carcinoma refractory to immunotherapyMaria Jove, Irene Braña, Marc Oliva, et al.
Pageof 3